Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome
- 1 November 1995
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 133 (1-2) , 95-101
- https://doi.org/10.1016/0022-510x(95)00162-u
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesPublished by Elsevier ,2004
- Synaptotagmin V: a novel synaptotagmin isoform expressed in rat brainFEBS Letters, 1995
- Calcium channel β-subunit binds to a conserved motif in the I–II cytoplasmic linker of the α1-subunitNature, 1994
- Distinctive biophysical and pharmacological properties of class A (BI) calcium channel α1 subunitsNeuron, 1993
- Expression of synaptotagmin and syntaxin associated with N‐type calcium channels in small cell lung cancerFEBS Letters, 1993
- On the structure of the ‘synaptosecretosome’ Evidence for a neurexin/synaptotagmin/syntaxin/Ca2+channel complexFEBS Letters, 1993
- Exo-endocytotic recycling of synaptic vesicles in developing processes of cultured hippocampal neuronsThe Journal of cell biology, 1992
- Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retinaNeuron, 1990
- The Inhibitory Effects of Omega‐Conotoxins on Ca Channels and SynapsesaAnnals of the New York Academy of Sciences, 1989
- Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone releaseAnnals of Neurology, 1987